PCT/1998/22 - World Intellectual Property Organization
PCT/1998/22 - World Intellectual Property Organization
PCT/1998/22 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>22</strong>/<strong>1998</strong><br />
9804 <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 4 Jun/juin <strong>1998</strong><br />
(54) 5–CYCLO INDOLE COMPOUNDS AS 5–HT1D<br />
RECEPTOR LIGANDS<br />
COMPOSES 5–CYCLO INDOLE EN TANT QUE<br />
LIGANDS DU RECEPTEUR DE 5–HT1D<br />
(71) ALLELIX BIOPHARMACEUTICALS INC.<br />
[CA/CA]; 6850 Goreway Drive, Mississauga,<br />
Ontario L4V 1V7 (CA).<br />
(72) SLASSI, Abdelmalik; 3237 Cambourne Crescent,<br />
Mississauga, Ontario L5N 5G4 (CA). EDWARDS,<br />
Louise; 35 Front Street S., #2800, Mississauga,<br />
Ontario L5H 2C6 (CA). MENG, Qingchang; 19<br />
McKinnon Avenue, Georgetown, Ontario L7G 5H5<br />
(CA). RAKHIT, Sumanas; 1110 Queen Street W.<br />
#26, Mississauga, Ontario L5H 4J4 (CA).<br />
(74) HIRONS, Robert, G. et al. / etc.; Ridout &<br />
Maybee, Suite 2400, One Queen Street, East,<br />
Toronto, Ontario M5C 3B1 (CA).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH HU ID<br />
IL IS JP KE KG KP KR KZ LC LK LR LS LT LU<br />
LV MD MG MK MN MW MX NO NZ PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TR TT UA UG<br />
UZ VN YU ZW; AP (GH KE LS MW SD SZ UG<br />
ZW); EA (AM AZ BY KG KZ MD RU TJ TM);<br />
EP(ATBECHDEDKESFIFRGBGRIEIT<br />
LU MC NL PT SE); OA (BF BJ CF CG CI CM<br />
GA GN ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/23588 (13) A1<br />
(21) <strong>PCT</strong>/GB97/03258<br />
(<strong>22</strong>) 27 Nov/nov 1997 (27.11.1997)<br />
(25) en (26) en<br />
(31) 9624817.4 (32) 28 Nov/nov 1996 (33) GB<br />
(28.11.1996)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 C07D 209/48, 401/12, C07K 5/06, A61K 31/40,<br />
38/00<br />
(54) METALLOPROTEINASE INHIBITORS<br />
INHIBITEURS DE METALLOPROTEINASES<br />
(71) BRITISH BIOTECH PHARMACEUTICALS<br />
LIMITED [GB/GB]; Watlington Road, Cowley,<br />
Oxford OX4 5LY (GB).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) FLOYD, Christopher, David [GB/GB]; British<br />
Biotech Pharmaceuticals Limited, Watlington<br />
Road, Cowley, Oxford OX4 5LY (GB).<br />
(74) WALLS, Alan, J.; British Biotech Pharmaceuticals<br />
Limited, Watlington Road, Cowley, Oxford OX4<br />
5LY (GB).<br />
(81) AU BR CA CN CZ GB HU IL JP KR MX NO NZ<br />
PL RU SG SK TR UA US; EP (AT BE CH DE<br />
DK ES FI FR GB GR IE IT LU MC NL PT SE).<br />
Published / Publiée : (c)<br />
(11) WO 98/23589<br />
(21) <strong>PCT</strong>/US97/16166<br />
(13) A1<br />
(<strong>22</strong>) 12 Sep/sep 1997 (12.09.1997)<br />
(25) en (26) en<br />
(31) 08/753,663 (32) 27 Nov/nov 1996<br />
(27.11.1996)<br />
(33) US<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 C07D 213/73, 215/40, 215/38, 215/42, 219/08<br />
(54) PROCESS FOR CONVERTING HYDROXY HE-<br />
TEROAROMATICS TO ARYLAMINES<br />
PROCEDE DE<br />
D’HETEROAROMATIQUES<br />
ARYLAMINES<br />
CONVERSION<br />
HYDROXY EN<br />
(71) HOECHST MARION ROUSSEL, INC.<br />
[US/US]; 2110 East Galbraith Road, P.O. Box<br />
156300, Cincinnati, OH 45215–6300 (US).<br />
(72) PEET, Norton, P.; 8028 Chestershire Drive, Cincinnati,<br />
OH 45241 (US). WEIDNER, John, J.;<br />
1135 Town and Four, Creve Coeur, MO 63141<br />
(US).<br />
(74) PAYNE, T., Helen; Hoechst Marion Roussel, Inc.,<br />
2110 East Galbraith Road, P.O. Box 156300, Cincinnati,<br />
OH 45215–6300 (US).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH HU IL<br />
IS JP KE KG KP KR KZ LC LK LR LS LT LU<br />
LV MD MG MK MN MW MX NO NZ PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TR TT UA UG<br />
UZ VN YU ZW; AP (GH KE LS MW SD SZ UG<br />
ZW); EA (AM AZ BY KG KZ MD RU TJ TM);<br />
EP (AT BE CH DE DK ES FI FR GB GR IE IT<br />
LU MC NL PT SE); OA (BF BJ CF CG CI CM<br />
GA GN ML MR NE SN TD TG).<br />
(11) WO 98/23590 (13) A1<br />
(21) <strong>PCT</strong>/FR97/02139<br />
(<strong>22</strong>) 27 Nov/nov 1997 (27.11.1997)<br />
(25) fr (26) fr<br />
(31) 96/14524 (32) 27 Nov/nov 1996<br />
(27.11.1996)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 C07D 213/75, A61K 31/44<br />
(33) FR<br />
(54) AROMATIC AMINES OF ARYLPIPERAZINES,<br />
THEIR PREPARATION AND APPLICATIONS<br />
AS MEDICINE<br />
AMINES AROMATIQUES<br />
D’ARYLPIPERAZINES, LEUR PRE-<br />
PARATION ET LEURS APPLICATIONS<br />
COMME MEDICAMENTS<br />
(71) PIERRE FABRE MEDICAMENT [FR/FR]; 45,<br />
place Abel Gance, F–92100 Boulogne–Billancourt<br />
(FR).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) HALAZY, Serge [BE/FR]; 1, place des Barrys,<br />
F–81090 Lagarrigue (FR). PEREZ, Michel<br />
[FR/FR]; 2, rue Ernst Barthe, F–81100 Castres<br />
(FR).<br />
(74) MARTIN, Jean–Jacques et al. / etc.; Cabinet<br />
Regimbeau, 26, avenue Kléber, F–75116 Paris<br />
(FR).<br />
(81) AU BR CA CN JP KR MX NZ US; EP (AT BE<br />
CH DE DK ES FI FR GB GR IE IT LU MC NL<br />
PT SE).<br />
Published / Publiée : (c)<br />
(11) WO 98/23591 (13) A1<br />
(21) <strong>PCT</strong>/US97/20550<br />
(<strong>22</strong>) 21 Nov/nov 1997 (21.11.1997)<br />
(25) en (26) en<br />
(31) 60/031,833 (32) 25 Nov/nov 1996<br />
(25.11.1996)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(33) US<br />
(51) 6 C07D 215/40, A61K 31/395, C07D 235/06<br />
(54) GUANIDINYLAMINO HETEROCYCLE<br />
COMPOUNDS USEFUL AS ALPHA–2<br />
ADRENOCEPTOR AGONISTS<br />
COMPOSES HETEROCYCLIQUES GUA-<br />
NIDINYLAMINO UTILES EN TANT<br />
QU’AGONISTES DE L’ADRENORECEPTEUR<br />
ALPHA–2<br />
(71) THE PROCTER & GAMBLE COMPANY<br />
[US/US]; One Procter & Gamble Plaza, Cincinnati,<br />
OH 45202 (US).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) CUPPS, Thomas, Lee [US/US]; 405 Pamela<br />
Drive, Oxford, OH 45056 (US). BOGDAN, Sophie,<br />
Eva [US/US]; 714 East Foster–Maineville<br />
Road, Maineville, OH 45039 (US). HENRY,<br />
Raymond, Todd [US/US]; 877 Hechterman Road,<br />
Pleasant Plain, OH 45162 (US). SHELDON,<br />
Russell, James [US/US]; 5023 Winton Road,<br />
Fairfield, OH 45014 (US). SEIBEL, William, Lee<br />
[US/US]; 5704 Somerset Drive, Hamilton, OH<br />
45011 (US). ARES, Jeffrey, Joseph [US/US];<br />
4176 Bennett Drive, Hamilton, OH 45011 (US).<br />
(74) REED, T. David et al. / etc.; The Procter &<br />
Gamble Company, 5299 Spring Grove Avenue,<br />
Cincinnati, Ohio 45217 (US).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH HU ID<br />
IL IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MD MG MK MN MW MX NO NZ PL PT<br />
RO RU SD SE SG SI SK SL TJ TM TR TT UA<br />
UG US UZ VN YU ZW; AP (GH KE LS MW SD<br />
SZ UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE); OA (BF BJ CF CG CI<br />
CM GA GN ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/23592 (13) A1<br />
(21) <strong>PCT</strong>/JP97/04326<br />
(<strong>22</strong>) 27 Nov/nov 1997 (27.11.1997)<br />
(25) ja (26) ja<br />
(31) 8/317693 (32) 28 Nov/nov 1996<br />
(28.11.1996)<br />
(31) 9/167245 (32) 24 Jun/juin 1997<br />
(24.06.1997)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 C07D 215/56, 401/04, 471/04, A61K 31/47<br />
(33) JP<br />
(33) JP<br />
(54) NOVEL PYRIDONECARBOXYLIC ACID DERI-<br />
VATIVES OR SALTS THEREOF AND DRUGS<br />
CONTAINING THE SAME AS THE ACTIVE IN-<br />
GREDIENT<br />
NOUVEAUX DERIVES D’ACIDE PYRIDONE-<br />
CARBOXYLIQUE OU LEURS SELS, ET MEDI-<br />
CAMENTS CONTENANT CEUX–CI EN TANT<br />
QUE PRINCIPE ACTIF<br />
(71) WAKUNAGA PHARMACEUTICAL CO., LTD.<br />
[JP/JP]; 5–36, Miyahara 4–chome, Yodogawa–ku,<br />
Osaka–shi, Osaka 532 (JP).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) SAKAE, Nobuya [JP/JP]; Wakunaga Pharmaceutical<br />
Co., Ltd., 1624, Shimokotachi, Kodacho,<br />
Takata–gun, Hiroshima 739–11 (JP). YAZAKI,<br />
Akira [JP/JP]; Wakunaga Pharmaceutical Co.,<br />
Ltd., 1624, Shimokotachi, Kodacho, Takata–gun,<br />
Hiroshima 739–11 (JP). KURAMOTO, Yasuhiro<br />
[JP/JP]; Wakunaga Pharmaceutical Co., Ltd., 1624,<br />
Shimokotachi, Kodacho, Takata–gun, Hiroshima<br />
739–11 (JP). YOSHIDA, Jiro [JP/JP]; Wakunaga<br />
Pharmaceutical Co., Ltd., 1624, Shimokotachi,<br />
Kodacho, Takata–gun, Hiroshima 739–11 (JP).<br />
NIINO, Yoshiko [JP/JP]; Wakunaga Pharmaceutical<br />
Co., Ltd., 1624, Shimokotachi, Kodacho,<br />
Takata–gun, Hiroshima 739–11 (JP). OSHITA,<br />
Yoshihiro [JP/JP]; Wakunaga Pharmaceutical<br />
Co., Ltd., 1624, Shimokotachi, Kodacho, Takata–gun,<br />
Hiroshima 739–11 (JP). HIRAO, Yuzo<br />
[JP/JP]; Wakunaga Pharmaceutical Co., Ltd., 1624,<br />
Shimokotachi, Kodacho, Takata–gun, Hiroshima<br />
739–11 (JP). HAYASHI, Norihiro [JP/JP]; Wakunaga<br />
Pharmaceutical Co., Ltd., 1624, Shimokotachi,<br />
Kodacho, Takata–gun, Hiroshima 739–11<br />
(JP). AMANO, Hirotaka [JP/JP]; Wakunaga<br />
Pharmaceutical Co., Ltd., 1624, Shimokotachi,<br />
Kodacho, Takata–gun, Hiroshima 739–11 (JP).
Change language